Prolonged SARS-CoV-2 Illness in a Patient Receiving Ocrelizumab for Multiple Sclerosis. uri icon

authors

  • Gibson, Elena G
  • Pender, Melissa
  • Angerbauer, Michael
  • Cook, Craig
  • Jones, Barbara
  • Adam Spivak, MD, FACP
  • Spivak, Emily S
  • Swaminathan, Sankar

publication date

  • January 1, 2021